MSM/5
Meeting of the Member State mechanism on substandard and falsified medical products
A/MSM/5/1
List of participants – Liste des Délégués
A/MSM/5/1
Provisional agenda
A/MSM/5/2
Understanding the links between access to quality, safe, efficacious and affordable medical products and the emergence of substandard, spurious, falsely-labelled, falsified, counterfeit (SSFFC) medical products
A/MSM/5/3
WHO’s participation in the Global Steering Committee for Quality Assurance of Health Products
A/MSM/5/4
A/MSM/5/4 Add.1
Review of the Member State mechanism on substandard/spurious/falsely-labelled/falsified/counterfeit medical products
A/MSM/5/5
Report of the informal technical working group on Activity A to develop recommendations for the health authorities engaged in the detection of substandard/spurious/falsely-labelled/falsified/ counterfeit (SSFFC) medical products and establish a strengthening and tool-generating programme to contribute to Member States’ training
A/MSM/5/6
Report of the informal working group on Activity C to survey the technologies, methodologies and “track and trace” models in place and to be developed to analyse their advantages and disadvantages and to survey the available authentication and detection technologies and methodologies and analyse their advantages and disadvantages
A/MSM/5/7
Report of the informal technical working group on draft working definitions of substandard/spurious /falsely-labelled/falsified/counterfeit (SSFFC) medical products
A/MSM/5/8
Report of the fifth meeting of the Member State mechanism on substandard/spurious/falsely-labelled/falsified/counterfeit medical products
